No definition available.
Other congenital malformations of integument, including avohilmo
Q17_OTHER_CONGEN_MALFO_INTEG_WIDE
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
126 |
4. Check minimum number of eventsNone |
126 |
5. Include endpointsNone |
126 |
6. Filter based on genotype QC (FinnGen only) |
113 |
Control definitions (FinnGen only)
- Control exclude
- Q17_OTHER_CONGEN_MALFO
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF13
- Parent code in ICD-10
- Q8
- Name in latin
- Aliae malformationes congenitae integumenti communis
Similar endpoints
↥List of similar endpoints to
Other congenital malformations of integument, including avohilmo
based on the number of shared cases.
Similar with more cases:
- Other congenital malformations, including avohilmo
- Congenital malformations, deformations and chromosomal abnormalities, including avohilmo
- Any operation in hilmo
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 113 | 59 | 54 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 61.67 | 59.49 | 64.05 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 119
- Matched controls
- 1190
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q84.5
ICD-10 Finland
Enlarged and hypertrophic nails
+∞
90.5
75
*
XCK10
NOMESCO Finland
Photography of fundus of eye
6.9
19.1
36
70
Z3226
NOMESCO Finland
Physiotherapist
4.3
12.9
46
151
L60
ICD-10 Finland
Nail disorders
78.5
12.9
14
*
R4110
NOMESCO Finland
Physiotherapy
4.0
12.4
58
230
E11
ICD-10 Finland
Type 2 diabetes mellitus
4.6
12.0
36
103
L84
ICD-10 Finland
Corns and callosities
13.9
11.9
20
17
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
3.7
11.5
62
268
Z2221
NOMESCO Finland
Medical doctor
3.8
11.3
54
215
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
12.3
10.7
19
18
A28
ICPC
Limited function/disability NOS
4.0
10.6
39
129
Q84.6
ICD-10 Finland
Other congenital malformations of nails
+∞
10.6
10
*
Q84.9
ICD-10 Finland
Congenital malformation of integument, unspecified
+∞
10.6
10
*
B35.1
ICD-10 Finland
Tinea unguium
5.6
10.5
22
46
ZXE10
NOMESCO Finland
More than one and less than three hours
3.5
10.3
62
283
L60.3
ICD-10 Finland
Nail dystrophy
108.3
9.6
10
*
Q84.8
ICD-10 Finland
Other specified congenital malformations of integument
+∞
9.5
9
*
R5110, ,
SPAT
4.8
9.0
23
57
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.6
8.8
37
133
I50
ICD-10 Finland
Heart failure
12.1
8.6
15
14
Z01.7
ICD-10 Finland
Laboratory examination
3.5
8.5
37
135
Z3231
NOMESCO Finland
Registered nurse
3.1
8.0
51
234
L17
ICPC
Foot/toe symptom/complaint
3.0
7.8
56
274
ZXE00
NOMESCO Finland
One hour or less
2.9
7.6
62
323
ZXD10
NOMESCO Finland
Scheduled procedure
2.9
7.6
58
293
L60.0
ICD-10 Finland
Ingrowing nail
6.9
7.1
17
28
Z71.8
ICD-10 Finland
Other specified counselling
2.8
7.0
55
279
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
8.7
6.8
14
18
WX002
NOMESCO Finland
Sedation and analgesia
3.1
6.8
35
140
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
3.9
6.8
22
65
A46
ICD-10 Finland
Erysipelas
3.3
6.6
30
111
ZXD35
NOMESCO Finland
Usual procedure
8.2
6.6
14
19
WX892
NOMESCO Finland
Monitored bed care
4.3
6.2
17
44
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.1
6.2
31
122
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.7
6.1
46
225
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
35
106
4.26
10.75
1.9
2.2
31.31
31.45
u/l
0.01
29
83
37
126
3.81
9.56
1.9
1.9
—
—
—
0
0
37
129
3.71
9.21
1.9
1.8
—
—
—
0
0
43
168
3.44
8.97
3.4
3.1
3.57
2.67
e6/l
0.22
21
81
42
168
3.32
8.36
2.0
2.0
—
—
—
0
0
43
182
3.13
7.71
3.3
2.9
0.89
0.93
e6/l
0.04
21
94
48
217
3.03
7.67
2.4
2.3
—
—
—
0
0
72
413
2.88
7.31
2.8
2.0
84.82
95.93
pmol/l
1.29
39
205
54
272
2.80
6.95
2.8
2.1
2.71
2.76
mg/l
0.05
46
238
15
26
6.44
6.07
1.7
1.4
—
—
—
0
0
15
26
6.44
6.07
1.7
1.4
—
—
—
0
0
56
313
2.49
5.57
3.6
3.0
1.10
0.46
e6/l
0.52
34
230
62
371
2.40
5.22
3.5
3.3
—
—
—
0
0
17
52
3.65
4.97
2.3
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
11
18
6.61
4.73
3.0
2.7
0.25
0.39
iu/ml
—
6
11
36
179
2.45
4.46
3.4
2.6
2.49
2.45
mmol/l
0.95
31
153
52
306
2.24
4.36
2.1
2.1
264.89
213.68
u/l
0.23
47
296
33
165
2.38
4.00
2.8
2.2
9.57
14.17
umol/l
2.32
28
154
20
78
2.88
3.96
8.0
9.7
24.39
24.90
mmol/l
0.20
20
78
19
72
2.95
3.96
3.8
2.4
385.74
175.63
ng/l
1.40
19
66
30
145
2.43
3.91
2.8
2.2
20.65
23.96
%
0.39
25
135
65
440
2.05
3.62
3.9
2.8
—
—
estimate
—
0
0
20
82
2.73
3.61
1.6
3.5
0.20
0.21
g/l
0.23
20
74
87
657
2.21
3.60
2.9
3.3
—
—
—
0
0
83
621
2.11
3.44
14.5
10.3
4.32
4.04
e9/l
0.48
74
549
48
296
2.04
3.41
2.0
1.7
20.26
21.37
nmol/l
0.15
43
250
105
874
2.71
3.22
38.0
19.3
14.15
13.61
%
2.37
105
863
16
65
2.69
2.93
18.9
10.5
94.29
92.68
%
0.69
16
65
80
610
1.95
2.91
7.9
5.8
7.48
6.52
mmol/l
2.54
74
570
7
14
5.24
2.77
3.4
2.9
—
—
—
0
0
41
257
1.91
2.68
3.9
3.1
351.63
343.37
umol/l
0.16
32
224
27
146
2.10
2.65
13.9
8.0
104.48
104.34
mmol/l
0.05
27
146
37
228
1.90
2.52
2.0
1.9
1.76
1.45
mg/l
0.24
29
186
28
157
2.02
2.50
1.4
1.7
756.48
1226.29
nmol/l
3.04
21
126
8
22
3.82
2.41
1.0
1.2
—
—
—
0
0
13
53
2.63
2.37
1.3
1.4
—
—
—
0
0
9
28
3.39
2.36
1.1
1.2
—
—
—
0
0
7
18
4.06
2.29
1.6
1.3
—
—
—
0
0
110
987
2.51
2.24
28.5
15.5
30.98
22.89
mg/l
1.69
99
786
13
55
2.53
2.21
1.6
1.4
—
—
—
0
0
107
940
2.37
2.18
5.9
5.2
1.78
1.90
mu/l
0.49
102
855
29
179
1.82
1.93
4.1
4.1
0.77
0.81
mmol/l
1.18
29
168
9
34
2.78
1.91
1.6
2.3
—
—
—
0
0
8
28
2.99
1.90
1.1
1.2
—
—
—
0
0
15
74
2.18
1.84
1.3
1.8
—
—
—
0
0
5
14
3.68
1.63
1.6
4.6
408.40
746.21
mg
—
5
14
20
319
0.55
1.63
3.9
3.7
0.00
0.00
estimate
—
10
112
41
294
1.60
1.57
1.5
1.4
2.10
1.81
u/ml
—
5
63
5
15
3.43
1.54
1.0
1.1
—
—
—
0
0
9
37
2.55
1.51
1.0
1.5
—
—
—
0
0
31
432
0.62
1.48
3.5
3.6
0.00
0.00
estimate
—
9
107
7
28
2.59
1.47
2.3
4.9
261.14
217.21
%
—
7
28
71
583
1.54
1.47
3.2
3.7
0.00
0.00
estimate
-0.00
11
113
14
74
2.01
1.46
1.4
2.3
—
—
—
0
0
88
764
1.58
1.37
4.4
4.4
18.89
11.27
mm/h
2.59
81
707
104
945
1.80
1.30
4.3
4.9
1.39
1.45
mmol/l
0.71
91
868
106
969
1.86
1.29
5.8
5.6
2.52
2.63
mmol/l
0.62
99
894
69
573
1.49
1.29
3.2
3.6
0.00
0.00
estimate
-0.00
11
124
104
949
1.76
1.23
4.5
4.9
4.36
4.53
mmol/l
0.97
92
881
8
38
2.18
1.21
3.6
2.0
40.88
46.95
u/l
—
8
33
17
103
1.76
1.20
4.1
3.6
—
—
—
0
0
69
578
1.46
1.20
3.2
3.6
0.00
0.00
estimate
-0.00
11
125
6
26
2.37
1.20
3.7
2.2
—
—
—
0
0
28
196
1.56
1.16
2.5
3.1
1.51
0.77
ug/l
0.29
13
130
12
66
1.91
1.13
1.4
2.2
—
—
—
0
0
55
446
1.43
1.12
3.2
2.5
74.17
75.10
nmol/l
0.08
50
404
7
32
2.26
1.10
2.3
4.6
87.57
89.38
%
—
7
32
78
678
1.44
1.06
3.0
3.6
61.06
50.18
u/l
0.50
70
645
86
771
1.42
0.90
4.9
4.4
14.71
14.86
pmol/l
0.23
80
702
98
902
1.49
0.87
3.9
4.2
1.30
1.26
mmol/l
0.26
85
824
26
194
1.44
0.80
1.3
1.3
15.54
32.68
iu/ml
—
8
68
6
33
1.86
0.80
1.2
1.3
—
—
—
0
0
0
24
0.00
0.80
0.0
1.4
—
171.37
—
0
6
29
222
1.41
0.78
1.7
1.8
—
—
—
0
0
7
38
1.89
0.75
1.1
1.3
—
—
—
0
0
5
25
2.04
0.73
1.6
1.3
—
—
—
0
0
32
258
1.33
0.63
3.6
4.7
20.59
22.29
%
—
9
127
0
21
0.00
0.60
0.0
1.8
—
213.36
—
0
11
25
313
0.75
0.60
3.0
3.5
0.00
0.00
estimate
—
10
104
0
22
0.00
0.60
0.0
2.2
—
89.39
—
0
14
39
326
1.29
0.59
6.6
3.8
26.67
11.07
mg/mmol
0.46
26
207
38
320
1.28
0.54
2.5
3.4
2743.51
1368.50
ng/l
0.56
38
270
100
946
1.36
0.54
5.4
5.0
6.24
5.96
mmol/l
0.80
94
858
20
253
0.75
0.51
3.3
3.4
1.02
1.02
kg/l
0.10
13
152
9
129
0.67
0.46
2.0
2.3
—
—
—
0
0
10
138
0.70
0.43
1.9
2.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
5
34
1.49
0.41
6.0
2.1
1.11
1.14
g/l
—
5
34
5
34
1.49
0.41
5.6
2.1
0.20
0.22
g/l
—
5
34
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
5
35
1.45
0.40
1.2
1.2
—
—
—
0
0
37
325
1.20
0.36
3.5
5.7
8.83
2.06
ug/l
0.41
32
287
8
109
0.71
0.30
10.3
6.9
—
—
—
0
0
12
94
1.31
0.29
1.3
1.3
—
—
—
0
0
8
66
1.23
0.27
1.1
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
6
53
1.14
0.09
4.5
2.1
47.77
60.01
u/ml
—
6
53
7
82
0.84
0.07
2.6
3.8
1.21
1.22
mmol/l
—
7
71
13
141
0.91
0.05
1.3
1.5
—
—
—
0
0
41
400
1.04
0.03
2.8
4.1
37.12
38.90
ng/l
0.04
19
288
20
205
0.97
0.00
1.5
1.8
479.93
65730809.88
pmol/l
0.50
15
178
0
5
0.00
0.00
0.0
3.4
—
10.30
—
0
5
0
5
0.00
0.00
0.0
1.2
—
45.54
—
0
5
0
5
0.00
0.00
0.0
1.2
—
115.22
—
0
5
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
17.00
—
0
6
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
10.27
—
0
6
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
1566.40
—
0
5
0
5
0.00
0.00
0.0
3.4
—
4.56
—
0
5
0
6
0.00
0.00
0.0
3.2
—
300.50
—
0
6
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.3
—
1.00
—
0
9
0
9
0.00
-0.00
0.0
3.6
—
46.30
—
0
9
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_OTHER_CONGEN_MALFO_INTEG_WIDE – Other congenital malformations of integument, including avohilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).